The Burrill Report
The Burrill Report (September 19, 2011): Pushing Policies in a Changed Washington (.MP3,15.09 Mb)
The Biotechnology Industry Organization at its annual convention at the end of June introduced an ambitious policy agenda for the next five years. Its intent, among other things, is to reduce the risk of investing in biotechnology companies and make the sector more attractive to investors. Less than three months later, as the trade group meets with legislators, much seems changed in both the financial markets and in the policy arena. We spoke to Alan Eisenberg, executive vice president of emerging companies and business development at BIO, about its policy roadmap, how new challenges created by the capital markets and the political environment in the last few months might alter its plans, and what it will take to get these policies implemented.
September 15, 2011